PortViewPortView
Eikon Therapeutics logo

Eikon Therapeutics (EIKN) Stock Analysis

NASDAQHealthcareBiotechnology

$10.83-0.46%
1-year price historyRange $8.36 – $16.26
52-week range$10.83
$7.90$17.40

What Eikon Therapeutics does

Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.

Key metrics

Market cap
$586.32M
P/E (TTM)
-0.37
EPS (TTM)
$-29.46
Beta
0.86
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$10.53
200-day avg
$11.12
52-week high
$17.40
52-week low
$7.90
CEO
Roger Perlmutter

ETFs linked to EIKN

Broad-market and Healthcare sector ETFs an investor holding Eikon Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how EIKN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze EIKN in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Eikon Therapeutics?
Eikon Therapeutics trades under the ticker EIKN on NASDAQ.
Which exchange is EIKN listed on?
EIKN is listed on NASDAQ.
What sector does Eikon Therapeutics operate in?
Eikon Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze EIKN in a portfolio?
PortView shows EIKN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.